Lakefront Biotherapeutics NV (LKFT)

Lakefront Biotherapeutics NV (LKFT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2B; returns 1 day +0.8%, 1 week +5.9%.

Lakefront Biotherapeutics NV (formerly Galapagos NV) is a commercial-stage biotechnology company that underwent a major strategic rebranding in May 2026 to reflect its pivot toward advanced immunology and oncology.

LKFT financial model: income statement, cash flow and balance sheet